Core Viewpoint - Zhonghong Medical (300981.SZ) is currently experiencing a decline in stock price, closing at 14.59 yuan with a drop of 3.63%, indicating a state of breaking down since its IPO in April 2021 [1] Group 1: IPO and Initial Performance - Zhonghong Medical was listed on the Shenzhen Stock Exchange's ChiNext on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1][2] - On its first trading day, the stock reached a peak price of 159.80 yuan, marking the highest price since its listing, but has since experienced a downward trend [2] - The total funds raised from the IPO amounted to 2.025 billion yuan, with a net amount of 1.896 billion yuan, exceeding the originally planned fundraising by 1.317 billion yuan [2] Group 2: Use of Proceeds and Financial Performance - The initial plan for the raised funds was 580 million yuan, allocated for the nitrile glove project at Jiangxi Zhonghong Pulin Medical Products Co., Ltd. and for supplementing working capital [2] - The total issuance costs for the IPO were 128 million yuan, with underwriting and sponsorship fees accounting for 107 million yuan [3] Group 3: Dividend Distribution - In 2022, the company announced a profit distribution plan, distributing 7.00 yuan in cash per 10 shares (including tax) and increasing the total share capital by 9 million shares through capital reserve [3] - For the 2021 fiscal year, the company distributed 30.00 yuan in cash per 10 shares (including tax) and increased the total share capital by 13.33 million shares [3] - A future dividend plan for June 10, 2025, includes a distribution of 2.5 yuan in cash per 10 shares (pre-tax) and a share increase of 1 share for every 10 shares held [4]
中红医疗跌3.63% 上市即巅峰超募13亿元